NANETs 2014

NANETS: Pancreastatin Predicts Survival in Patients with Neuroendocrine Tumors

NANETS: Pancreastatin Predicts Survival in Patients with Neuroendocrine Tumors

By

Higher pancreastatin associated with worse survival times in surgically treated small bowel (SBNET) and pancreatic neuroendocrine tumors (PNETs).

NANETS: Lymph Node Ratio Predicts Survival in Patients with Gastrointestinal (GI) Carcinoid Neuroendocrine Tumors

NANETS: Lymph Node Ratio Predicts Survival in Patients with Gastrointestinal (GI) Carcinoid Neuroendocrine Tumors

By

Lymph node ratio (LNR) may offer better survival prediction over the current measure for patients with carcinoid neuroendocrine tumors.

Some Locally-Advanced and Metastatic Pulmonary Carcinoid Tumors Respond to Chemotherapy

Some Locally-Advanced and Metastatic Pulmonary Carcinoid Tumors Respond to Chemotherapy

By

Octreotide has demonstrated promising results vs. a subset of carcinoid tumors, despite a lower overall response rate.

Gene Panel Identifies Primary Tumor Sites in Metastatic Neuroendocrine Tumors

Gene Panel Identifies Primary Tumor Sites in Metastatic Neuroendocrine Tumors

By

A 3-marker immunohistochemistry panel helps determine the primary site of malignancy in metastatic neuroendocrine tumors.

Tumor-Specific Mutations More Common in High-Grade Neuroendocrine Tumors

Tumor-Specific Mutations More Common in High-Grade Neuroendocrine Tumors

By

Tumor-specific mutations are common in high-grade neuroendocrine tumors.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs